检索

期
标题
作者
卷 13, 编号 1 (2023)
The place of antiretroviral therapy in the behavioral strategies aimed at maintaining the health and quality of counseling of people living with HIV
Kozyrina N., Belyaeva V., Ekaterina S., Semikova S., Lebedeva E., Gavrilova O., Galiullin N., Beshimov A., Khoraskina E., Narkevich A., Suvorova Z., Khokhlova O.
PDF
(Rus)
卷 13, 编号 3 (2023)
Human immunodeficiency virus and death
Pokrovsky V.
PDF
(Rus)
卷 13, 编号 3 (2023)
Impact of antiretroviral therapy on the development of the HIV-infection epidemic in the Russian Federation
Sokolova E., Ladnaia N., Pokrovsky V., Kravchenko A., Kozyrina N., Yurin O., Chekryzhova D.
PDF
(Rus)
卷 13, 编号 3 (2023)
Two-drug antiretroviral therapy regimen with dolutegravir and lamivudine for previously untreated HIV-infected patients
Koshkin A., Pokrovskaya A.
PDF
(Rus)
卷 11, 编号 2 (2021)
The spectrum of adverse events in the treatment of multidrug-resistant tuberculosis among people receiving antiretroviral therapy
Degtyareva S., Zimina V., Pokrovskaya A., Konovalova A., Volchenkov G.
PDF
(Rus)
编号 2 (2014)
Experience with enfuvirtide (fuzeon) in the treatment regimens for HIV infection
Beketova E., Bykov S.
PDF
(Rus)
卷 11, 编号 3 (2021)
HIV-1 drug resistance in patients with virological inefficiency on ART in Russia in 2013-2021
Kirichenko A., Kireev D., Shlykova A., Lopatukhin A., Lapovok I., Saleeva D., Kravchenko A., Pokrovsky V.
PDF
(Rus)
编号 1 (2017)
Combined antiretroviral drugs containing lamivudine and zidovudine for the treatment of HIV infection
Sizova N., Korneeva T., Bratkova V., Sotnikova A., Rassokhin V.
PDF
(Rus)
编号 3 (2015)
Antiretroviral therapy regimens containing the HIV protease inhibitor saquinavir
Kravchenko A.
PDF
(Rus)
编号 3 (2014)
Experience with the HIV protease inhibitor fosamprenavir in first-line antiretroviral therapy regimens in the Chelyabinsk Region
Moskvicheva M., Radzikhovskaya M.
PDF
(Rus)
编号 1 (2013)
USE OF THE FUSION INHIBITOR ENFUVIRTIDE IN ANTIRETROVIRAL THERAPY REGIMENS FOR HIV-INFECTED PATIENTS
Kravchenko A., Kanestri V.
PDF
(Rus)
编号 4 (2016)
Phosphaside and lamivudine as a nucleoside base of first-line antiretroviral therapy regimens for HIV infection
Ivanova E.
PDF
(Rus)
编号 2 (2015)
EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING ETRAVIRINE FOR HIV-INFECTED PATIENTS
KRAVCHENKO A., KANESTRI V., GANKINA N.
PDF
(Rus)
编号 3 (2014)
Lipodystrophy syndrome in patients with HIV infection
Khasanova G.
PDF
(Rus)
编号 3 (2012)
THE NOVEL HIV NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR RILPIVIRINE: A REVIEW OF INTERNATIONAL CLINICAL TRIALS
KANESTRI V.
PDF
(Rus)
卷 10, 编号 3 (2020)
THE PROBLEM OF BODY WEIGHT GAIN IN HIV-INFECTED PATIENTS DURING ANTIRETROVIRAL THERAPY
KRAVCHENKO A., KANESTRI V.
PDF
(Rus)
编号 4 (2016)
Results of examination of pregnant women’s sexual partners for HIV infection: The experience of the Sverdlovsk Region
Podymova A.
PDF
(Rus)
编号 1 (2015)
A fixed-dose combination of abacavir/lamivudine as a nucleoside basis for first-line antiretroviral therapy regimens
Konnov V., Kozyreva N., Kanestri V., Narsia R., Yurin O.
PDF
(Rus)
编号 1 (2012)
COST-MINIMIZATION ANALYSIS OF ETRAVIRINE AND RALTEGRAVIR USED IN THERAPY FOR HIV INFECTION
BELOUSOV Y., AFANASYEVA E., BELOUSOV D., BEKETOV A.
PDF
(Rus)
卷 9, 编号 2 (2019)
Influenza in the HIV infected
Provorova V., Krasnova E., Khokhlova N., Kuimova I., Izvekova I.
PDF
(Rus)
编号 2 (2016)
Use of non-boosted atazanavir in clinical practice
Kanestri V., Yagodkin M.
PDF
(Rus)
编号 1 (2015)
Hepatotoxicity of antiretroviral therapy in HIV-infected patients
Kanestri V., Kravchenko A., Gankina N.
PDF
(Rus)
编号 6 (2013)
CONTRIBUTION OF A FIXED-DOSE ABACAVIR/LAMIVUDINE COMBINATION TO IMPROVING TREATMENT COMPLIANCE IN HIV-INFECTED PATIENTS
KANESTRI V.
PDF
(Rus)
编号 2 (2011)
ATAZANAVIR IN BASIC ANTIRETROVIRAL THERAPY REGIMENS: A REVIEW OF CONVINCING DATA
MAKSIMOV S.
编号 6 (2015)
The first results of using the combined drug rilpivirine/tenofovir/ emtricitabine in Russian patients with HIV infection in real clinical practice
Sizova N., Volova L., Malyuzhenko I., Isaeva G., Koveleno A., Minaeva S., Topolskaya S., Voronin E., Okhonskaya L.
PDF
(Rus)
编号 6 (2013)
PROSPECTS FOR THE LONG-TERM EFFICACY OF FOSAMPRENAVIR (TELZIR) USED AS PART OF ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS
GUSHCHINA Y., KUVAEVA M.
PDF
(Rus)
卷 12, 编号 2 (2022)
USE OF A FIXED-DOSE ANTIRETROVIRAL DRUG IN HIV-INFECTED PREGNANT WOMEN
Samarina A., Mozaleva O., Martirosian M., Skryabneva T.
PDF
(Rus)
编号 2 (2011)
THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS
KRAVCHENKO A., KANESTRI V.
编号 6 (2015)
HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
Kravchenko A., Kanestri V.
PDF
(Rus)
编号 6 (2014)
DUAL ANTIRETROVIRAL THERAPY WITH LOPINAVIR AND RITONAVIR
Yurin O., KRAVCHENKO A., KANESTRI V., POKROVSKAYA A., SHAKHGILDYAN V., VOLKOVA S.
PDF
(Rus)
编号 5 (2013)
CLINICOECONOMIC ANALYSIS OF THE USE OF MARAVIROC VERSUS OTHER RESERVE DRUGS IN PATIENTS WHO HAVE EXPERIENCED ANTIRETROVIRAL THERAPY FOR HIV INFECTION
PYADUSHKINA E., GORYAYNOV S., OMELYANOVSKY V., AVXENTYEVA M., REBROVA O.
PDF
(Rus)
卷 11, 编号 4 (2021)
Studying the transmission of HIV-1 drug resistance in the Republic of Armenia using bioinformatics methods
Osadchaya O., Eroshkin P., Kirichenko A., Lapovok I., Saleeva D., Lopatukhin A., Shlykova A., Kireev D., Grigoryan T., Petrosyan A., Sarhatyan T., Pokrovsky V.
PDF
(Rus)
编号 1 (2011)
MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME DURING ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV INFECTION
KRAVCHENKO A., ZIMINA V., VIKTOROVA I., SITDYKOVA Y.
编号 6 (2015)
A virologic response as a hallmark of excellence: TDF/FTC or TDF/3TC
Kozyrina N., Yurin O.
PDF
(Rus)
编号 5 (2014)
ABAKAVIR I LAMIVUDIN KAK NUKLEOZIDNAYa OSNOVA ANTIRETROVIRUSNOY TERAPII
KOZYRINA N., NARSIA R., YURIN O.
PDF
(Rus)
编号 4 (2013)
EXPERIENCE WITH THE HIV PROTEASE INHIBITOR FOSAMPRENAVIR IN RUSSIAN PRACTICE
VOLKOVA S., PODYMOVA A.
PDF
(Rus)
卷 11, 编号 3 (2021)
The use of doravirme as part of antiretroviral therapy regimens in patients with resistance mutations
Orlova-Morozova E., Pronin A.
PDF
(Rus)
编号 3 (2017)
The demographic and clinical characteristics of HIV-infected women in routine clinical practice in the Russian Federation: Results of a multicenter crosssectional non-interventional study
Voronin E., Afonina L., Orlova-Morozova E., Plotnikova Y., Radzikhovskaya M.
PDF
(Rus)
编号 5 (2015)
The efficacy and safety of a new Russian HIV non-nucleoside reverse transcriptase inhibitor (VM-1500, Elpivirine) as a component in an antiretroviral therapy regimen
Kravchenko A., Orlova-Morozova E., Shimonova T., Kozyrev O., Nagimova F., Bychko V., Vostokova N., Zozulya O.
PDF
(Rus)
编号 4 (2014)
USE OF A COMBINATION OF THE ANTIRETROVIRAL DRUGS DARUNAVIR ® AND ETRAVIRINE ® IN A PATIENT WITH A RESISTANT HIV STRAIN
MIKOVA O., MOISEEVA G.
PDF
(Rus)
编号 4 (2013)
CLINICAL AND LABORATORY FEATURES OF ABNORMALITIES IN THE CERVIX UTERI, EXTERNAL GENITALS, AND VAGINA IN HIV-INFECTED PATIENTS
SUNDUKOV A., GAFUROV Y., EVSYUKOV O.
PDF
(Rus)
1 - 41 的 41 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##